Taysha Gene Therapies (TSHA) Competitor Comparison
We are evaluating the key criteria listed to compare Taysha Gene Therapies (TSHA) against its competitors in the Biotechnology industry.
Market Capitalization
177 / 368Gross Profits
117 / 278Total Revenue
173 / 300EBITDA
164 / 337Free Cashflow
16 / 352Quick Ratio
331 / 357Earnings per Share
83 / 359Dividend yield
0 / 6Total Cash
181 / 358Performance 3 years
264 / 368Performance 5 years
276 / 368Performance 10 years
244 / 368Linearity 3 years
279 / 368Linearity 5 years
244 / 368Linearity 10 years
222 / 368Total Rank
275 / 368Dividend Rank
283 / 368Valuation Rank
66 / 368Piotroski Rank
170 / 368Muliplier Rank
59 / 368Market Capitalization - TSHA ranking 177 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.